Lilly Completes Acquisition of Prevail Therapeutics

INDIANAPOLIS , Jan. 22, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The acquisition establishes a new modality for drug discovery and development at Lilly , extending Lilly 's